INT150252

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.41
First Reported 2008
Last Reported 2008
Negated 0
Speculated 0
Reported most in Body
Documents 3
Total Number 3
Disease Relevance 1.73
Pain Relevance 0.23

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

cell proliferation (IL2RA) plasma membrane (IL2RA)
Anatomy Link Frequency
plasma 1
IL2R 1
T cell 1
IL2RA (Homo sapiens)
Pain Link Frequency Relevance Heat
Inflammatory response 2 100.00 Very High Very High Very High
Pain 2 96.32 Very High Very High Very High
Inflammation 5 92.48 High High
tolerance 1 69.32 Quite High
Paracetamol 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
INFLAMMATION 6 100.00 Very High Very High Very High
Pressure And Volume Under Development 1 98.04 Very High Very High Very High
Increased Venous Pressure Under Development 1 97.12 Very High Very High Very High
Pain 1 96.32 Very High Very High Very High
Cancer 13 96.12 Very High Very High Very High
Fever 1 95.08 Very High Very High Very High
Necrosis 3 93.00 High High
Shock 3 85.52 High High
Disease 5 65.28 Quite High
Metastasis 2 63.52 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Moreover, in RAS, Treg cells were nearly twice less potent in the inhibition of CD4(+)CD25(-) T cell proliferation than in healthy donors.
Negative_regulation (inhibition) of CD25 in T cell
1) Confidence 0.41 Published 2008 Journal J. Oral Pathol. Med. Section Body Doc Link 18318707 Disease Relevance 0 Pain Relevance 0
The Bangladesh and Taiwan studies and our U.S. study all observed a decrease in inflammatory response pathway members, including interleukins such as IL2R (Argos et al. 2006) and IL1 ?
Negative_regulation (decrease) of IL2R in IL2R associated with inflammatory response
2) Confidence 0.36 Published 2008 Journal Environ Health Perspect Section Body Doc Link PMC2290973 Disease Relevance 0.59 Pain Relevance 0.08
The column demonstrated safety and efficacy in lowering plasma sTNF-R1, sTNF-R2, and sIL2-R levels.
Negative_regulation (lowering) of sIL2-R in plasma
3) Confidence 0.03 Published 2008 Journal Ther Apher Dial Section Abstract Doc Link 19140848 Disease Relevance 1.14 Pain Relevance 0.14

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox